[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"dvt---deep-vein-thrombosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:dvt---deep-vein-thrombosis":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,47,70,95],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100651699","outcomes-of-iliac-vein-stenting-with-dedicated-venous-stents-in-treatment-of-chronic-post-thrombotic-venous-ulcers-100651699",false,"NCT07762222","Outcomes of Iliac Vein Stenting With Dedicated Venous Stents in Treatment of Chronic Post-thrombotic Venous Ulcers","Inclusion Criteria:\n\n* Chronic non-healing venous ulcer associated with iliofemoral post-thrombotic syndrome.\n* CEAP clinical classification C6.\n* Iliofemoral post-thrombotic venous obstruction confirmed by appropriate venous imaging.\n* Age 18 years or older.\n* Ability to provide informed consent.\n\nExclusion Criteria:\n\n* Nonthrombotic iliac vein lesion (NIVL).\n* Post-phlebitic femoropopliteal venous lesions with a patent iliac vein.\n* CEAP clinical classification other than C6.\n* Previous venous intervention.\n* Active pathological ulcer unrelated to post-thrombotic venous disease.\n* Life expectancy less than 2 years.\n* Pregnancy.\n* Known allergy to contrast media.\n* Contraindication to anesthesia.\n* Refusal to participate or inability to provide informed consent.","ALL","18 Years","70 Years",{"count":19,"type":20},20,"ESTIMATED","INTERVENTIONAL",[23],"NA","Outcomes of iliac vein stenting with dedicated venous stents in treatment of chronic post-thrombotic venous ulcers Deep vein thrombosis (DVT) affects 1 to 3 individuals per 1000 annually. Among these patients, 20% to 50% may develop post-thrombotic syndrome (PTS), with the likelihood varying based on the extent and location of the thrombus. Notably, despite receiving anticoagulation therapy, 5% to 10% of patients may progress to severe PTS, potentially leading to the development of venous ulcers (Afsha Aurshina, 2018). Chronic venous obstruction (CVO) refers to the impediment of venous flow, typically resulting from either partial or complete blockage of the venous system. This obstruction leads to diminished venous flow and elevated pressure within the affected veins. CVO serves as a broad descriptor for various conditions, including post-thrombotic syndrome (PTS) and nonthrombotic iliac vein lesions (NIVLs). PTS commonly arises as a complication of deep vein thrombosis (DVT), with estimates indicating that up to 50% of patients diagnosed with iliofemoral DVT will develop PTS within two years following their initial diagnosis. (Mohammad E. Barbati, 2024)\n\nThe study aims to know the outcomes of iliac vein stenting with dedicated venous stenting in the treatment of post-thrombotic syndrome venous ulcer.\n\nType of Study: Prospective single arm cohort study\n\n* Study Setting: Ain Shams University hospitals\n* Study Period: 2 years with 6 months follow up\n* Sample Size: 20 patients.\n* Study Population Patients presenting to the outpatient clinic at Ain Shams University Hospitals with venous ulcers.\n* Study Tools\n\n  * 20 patients will be selected.\n  * Written informed consent.\n  * Full history taking, personal history , risk factors of DVT, presence of any medical illness , assessment of QOL based on CVIQ 20 - questionnaire, list of symptoms, sensations or types of discomfort that you may or may not be experiencing and which may make everyday life hard to bear to a greater or lesser extent.\n  * Clinical evaluation: based on revised Venous Clinical Severity Score rVCSS , Villalta score and CEAP classification . rVCSS includes 10 items, such as pain, varicose veins, oedema, skin pigmentation, inflammation, skin induration, number of active ulcers, ulcer size, duration of ulcer, and application of pressure therapy. Each item is scored from 0 to 3 according to the severity, and the total score is 30. A higher score indicates higher severity. And using villlata score It can be used to both diagnose and categories the severity of the condition. The Villalta score involves both the patient who grades the presence and severity (0-3 points) of five symptoms ( pain , cramps, heaviness, parasthesia and pruritus ) and and the physician who grades six clinical signs(Pre-tibial oedema, Hyper-pigmentation, Redness, Venous Ectasia, ain on calf compression, ulcers) (0-3 points) after examination of the lower limb. Also the clinical severity of the venous disease will be graded according to the clinical, etiological, anatomical, and pathophysiological (CEAP) scoring system, and assessment of venous ulcer assessment (by onset, course, duration, site, size, shape",[26,27,28,29],"Vascular","DVT - Deep Vein Thrombosis","Post Thrombotic Syndrome","Venous Ulcer of Leg",[31,32,33],"iliofemoral postthrombotic syndrome","venous ulcer","dedicated iliac venous stenting","RECRUITING","2026-08-08",{"date":37,"type":38},"2026-08-13","ACTUAL",{"date":40,"type":38},"2025-03-02",{"date":42,"type":20},"2027-01-01",{"name":44,"class":45},"Ain Shams University","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":55,"targetDuration":4,"studyType":57,"phases":4,"briefSummary":58,"conditions":59,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":46},"100593702","clinical-application-of-wearable-ultrasound-sensors-100593702","NCT07009873","Clinical Application of Wearable Ultrasound Sensors","Clinical Application on the R&D Purpose of Wearable Ultrasound Sensors:A Single-Center Prospective Study","Inclusion Criteria:\n\n* Age ≥ 18 yrs and able to consent\n* Relevant diagnosis for study arm (heart failure, lower-limb DVT, or ICU monitoring)\n* Adequate acoustic window and intact skin at sensor site\n\nArm-specific:\n\n* Heart-failure arm: Clinically stable HFrEF or HFpEF on standard therapy\n* DVT arm: Imaging-confirmed lower-limb DVT, anticoagulated or scheduled for intervention\n* ICU arm: ICU\u002Fpost-op patient requiring continuous bedside ultrasound\n\nExclusion Criteria:\n\n* Poor acoustic window preventing interpretable images\n* Local skin infection, open wound, or implant\u002Fhardware blocking sensor\n* Inability to cooperate with monitoring\n\nArm-specific:\n\n* Heart-failure arm: Acute MI or uncontrolled arrhythmia in past 3 months\n* DVT arm: Active bleeding or severe coagulopathy\n* ICU arm: Unstable multi-organ failure precluding safe monitoring",true,{"count":56,"type":20},300,"OBSERVATIONAL","This study aims to develop and evaluate a wearable ultrasound imaging sensor for the early diagnosis and real-time monitoring of various diseases, such as cardiovascular conditions and structural abnormalities of superficial organs. With advancements in medical technology, wearable devices have attracted increasing attention for their portability and real-time capabilities.",[27,60],"POCUS","2026-03-18",{"date":63,"type":38},"2026-03-20",{"date":65,"type":38},"2025-08-15",{"date":67,"type":20},"2026-09-30",{"name":69,"class":45},"Chinese PLA General Hospital",{"id":71,"slug":72,"hasResults":11,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":78,"targetDuration":4,"studyType":57,"phases":4,"briefSummary":80,"conditions":81,"keywords":83,"overallStatus":85,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":46},"100572396","padua-prediction-score-for-vte-risk-in-thoracic-surgery-patients-100572396","NCT06732726","Padua Prediction Score for VTE Risk in Thoracic Surgery Patients","Assessment of the Padua Prediction Score for Venous Thromboembolism Risk Stratification in Thoracic Surgery Patients: Insights From a Single-Center Cohort Study in Iraq","DVT","Inclusion Criteria:\n\n* Patients who have undergone preoperative Padua Prediction Score assessment.\n* Inpatients with a hospital stay over 3 days\n* Written informed consent obtained from patients or their legal guardians.\n* Availability for postoperative follow-up to assess outcomes like LEVT development or related complications.\n\nExclusion Criteria:\n\n* Preexisting LEVT or pulmonary embolism.\n* Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease).\n* receiving any anticoagulation therapy for any reason.\n* patients who did not undergo a postoperative D-dimer test.\n* Incomplete Data: missing essential clinical or laboratory data.\n* Pregnancy: pregnant women or those within six weeks postpartum.\n* Noncompliance: Patients unwilling or unable to adhere to study follow-up protocols.",{"count":79,"type":20},150,"The goal of this observational study is to assess the predictive accuracy of the Padua Prediction Score (PPS) for venous thromboembolism (VTE) risk in thoracic surgery patients.\n\nThe study aims to answer the following question:\n\nDoes the PPS provide a more accurate prediction of VTE risk?\n\nParticipants will:\n\nHave their VTE risk assessed using the PPS during their hospital admission.",[27,82],"VTE (Venous Thromboembolism)",[84],"Padua Prediction Score (PPS)","NOT_YET_RECRUITING","2025-03-16",{"date":88,"type":38},"2025-03-18",{"date":90,"type":20},"2025-04-20",{"date":92,"type":20},"2025-07-15",{"name":94,"class":45},"Al-Nahrain University",{"id":96,"slug":97,"hasResults":11,"nctId":98,"briefTitle":99,"officialTitle":100,"acronym":76,"eligibilityCriteria":101,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":102,"targetDuration":4,"studyType":57,"phases":4,"briefSummary":104,"conditions":105,"keywords":106,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":109,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":46},"100572111","predictive-value-of-modified-caprini-score-and-d-dimer-in-managing-lower-limb-venous-thrombosis-in-cardiothoracic-patients-100572111","NCT06729021","Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients","Predictive Efficacy of Modified Caprini Score and D-Dimer for the Evaluation and Management of Lower Extremity Venous Thrombosis Among Cardiothoracic Surgery Patients in Baghdad","Inclusion Criteria:\n\n* Inpatients with a hospital stay over 3 days\n* Written informed consent obtained from patients or their legal guardians.\n* Availability for postoperative follow-up to assess outcomes like LEVT development or related complications.\n\nExclusion Criteria:\n\n* Preexisting LEVT or Pulmonary Embolism: Diagnosed before the index surgery.\n* Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease).\n* receiving any anticoagulation therapy for any reason.\n* patients who did not undergo a postoperative D-dimer test.\n* Incomplete Data: missing essential clinical or laboratory data for Modified Caprini Score calculation or D-Dimer measurement.\n* Pregnancy: pregnant women or those within six weeks postpartum.\n* Noncompliance: Patients unwilling or unable to adhere to study follow-up protocols.",{"count":103,"type":20},112,"The goal of this observational study is to evaluate the predictive efficacy of the Modified Caprini Risk Assessment Score and D-Dimer in identifying and managing lower extremity venous thrombosis (LEVT) among cardiothoracic surgery patients in Baghdad. The main questions it aims to answer are:\n\nDoes combining the Modified Caprini Score with D-Dimer improve the accuracy of predicting lower extremity venous thrombosis (LEVT) compared to using each tool independently? Can these tools effectively guide clinical decisions for lower extremity venous thrombosis (LEVT) prevention and management in this patient population?\n\nParticipants will:\n\nUndergo risk assessment for lower extremity venous thrombosis (LEVT) using the Modified Caprini Score and have their D-Dimer levels measured during their hospital stay.\n\nBe monitored for clinical outcomes, including confirmed lower extremity venous thrombosis (LEVT) incidence, need for anticoagulation therapy, and complications such as pulmonary embolism or recurrent thrombosis.",[27],[107,108,76],"Caprini Score","D-Dimer",{"date":88,"type":38},{"date":111,"type":38},"2025-01-20",{"date":113,"type":20},"2025-07-30",{"name":94,"class":45}]